Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of FlutiForm vs Fluticasone in Moderate to Severe Asthma
NCT00649025Phase 3Completed
- Sponsor
- Skyepharma
- Start
- Mar 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 3, randomised, double-blind trial of formoterol in asthma (3 arms), sponsored by Skyepharma. Primary endpoint: Change in FEV1 from morning pre-dose at Baseline to 2 hours post-dose. Started Mar 2008; status: completed.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00649025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00649025.